This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Alchemia Limited. Active years: 2010-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2011
Title: Innovations by Matthias Grathwohl
Introduction
Matthias Grathwohl is a notable inventor based in Constance, Germany. He has made significant contributions to the field of drug discovery through his innovative work on disaccharides. With a total of 2 patents, Grathwohl's inventions focus on developing compounds that can lead to novel therapeutic agents.
Latest Patents
Grathwohl's latest patents include methods for preparing combinatorial libraries of potentially biologically active disaccharide compounds. These compounds are designed to be variously functionalized to enhance lipid solubility, size, function, and other properties. The aim is to discover new drug or drug-like compounds with useful characteristics. His invention provides intermediates, processes, and synthetic strategies for both solution and solid-phase synthesis of disaccharides, which include the addition of aromaticity and charge, as well as the incorporation of pharmaceutically useful groups and isosteres. Another significant patent focuses on carbohydrate-based anti-bacterials, detailing a method of inhibiting bacterial growth by using disaccharide compounds of General Formula I.
Career Highlights
Grathwohl is currently associated with Alchemia Limited, where he continues to push the boundaries of drug discovery. His work has been instrumental in developing new methodologies that can potentially revolutionize the pharmaceutical industry.
Collaborations
Grathwohl has collaborated with notable colleagues such as Bernd Becker and Wim F Meutermans, contributing to a rich environment of innovation and research.
Conclusion
Matthias Grathwohl's contributions to the field of drug discovery through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile